| Chelsea Libreros-cortes, | |
|
508 10th Ave, Belmar, NJ 07719-2317 | |
| (732) 910-9196 | |
| Not Available |
| Full Name | Chelsea Libreros-cortes |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 508 10th Ave, Belmar, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821728965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS01144800 (New Jersey) | Primary |
| Provider Name | Coastal Home Rehabilitation, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1316236664 PECOS PAC ID: 0345418646 Enrollment ID: O20110712000231 |
News Archive
Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.
The European Quality in Preclinical Data (EQIPD) consortium has announced the official finalisation of the EQIPD Innovative Medicines Initiative (IMI) project.
A new study suggests that children who typically receive an operation to insert ear tubes because of ear infections or fluid in the ear may not need it, according to clinical practice guidelines.
› Verified 9 days ago
| Provider Name | Link Home Services Of Nj Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1972072585 PECOS PAC ID: 9133551765 Enrollment ID: O20191119002707 |
News Archive
Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.
The European Quality in Preclinical Data (EQIPD) consortium has announced the official finalisation of the EQIPD Innovative Medicines Initiative (IMI) project.
A new study suggests that children who typically receive an operation to insert ear tubes because of ear infections or fluid in the ear may not need it, according to clinical practice guidelines.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Libreros-cortes, Po Box 851, Belmar, NJ 07719-0851 Ph: (732) 910-9196 | Chelsea Libreros-cortes, 508 10th Ave, Belmar, NJ 07719-2317 Ph: (732) 910-9196 |
News Archive
Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers.
The European Quality in Preclinical Data (EQIPD) consortium has announced the official finalisation of the EQIPD Innovative Medicines Initiative (IMI) project.
A new study suggests that children who typically receive an operation to insert ear tubes because of ear infections or fluid in the ear may not need it, according to clinical practice guidelines.
› Verified 9 days ago
Eleanor Tier, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 508 10th Ave, Belmar, NJ 07719 Phone: 908-670-6695 Fax: 732-894-3475 | |
Allison Lebovitz, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 508 10th Ave, Belmar, NJ 07719 Phone: 732-910-9196 | |
Danielle Castellano, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 508 10th Ave, Belmar, NJ 07719 Phone: 732-910-9196 | |
Mary Carlson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 C St, Belmar, NJ 07719 Phone: 973-868-5216 | |
Marissa Bianco, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 508 10th Ave, Belmar, NJ 07719 Phone: 732-910-9196 | |
Taylor Dino, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 508 10th Ave, Belmar, NJ 07719 Phone: 732-910-9196 | |
Julianne Minutillo, M.S. ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 13th Ave, Belmar, NJ 07719 Phone: 908-331-3948 |